Customs exemption amendments increase ad valorem rates and revise exempted inputs for pharmaceutical manufacture and rename certain entries. Amendments revise exempted inputs and substitute specified ad valorem rates in Notifications 64/79, 58/85, 67/91, 53/92 and 251/92; they insert, substitute or omit table entries naming inputs and intermediates for pharmaceutical manufacture and add an entry for Melagenina.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Customs exemption amendments increase ad valorem rates and revise exempted inputs for pharmaceutical manufacture and rename certain entries.
Amendments revise exempted inputs and substitute specified ad valorem rates in Notifications 64/79, 58/85, 67/91, 53/92 and 251/92; they insert, substitute or omit table entries naming inputs and intermediates for pharmaceutical manufacture and add an entry for Melagenina.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.